Menu

Using UNC's expertise to fight emerging diseases


Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related:

Instagram account uncquirks serves as digital scrapbook of on-campus life
The University of North Carolina is full of personality — possums in trash cans, unicycles made from Jordans and Squidward-shaped snowmen in the winter time...

UNC students face flood damage from Chantal on and off campus, may be eligible for University aid
On Sunday, July 6, Chapel Hill and surrounding areas faced heavy rain and flooding from Tropical Storm Chantal, which damaged some University of North Carolina...

Parts of Chapel Hill return to business. Others remain in limbo after Chantal
Remnants of Tropical Storm Chantal left many stores and restaurants in Chapel Hill submerged in 5 feet of water. Eastgate Crossing and Mariakakis Plaza were...

Excellence Unveiled: Karsen Kitchen
In the sixth installment of Excellence Unveiled, listen to Karsen Kitchen, class of 2025, discuss her 20-minute journey aboard a Blue Origin rocket and her...


© 2005-2025 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.